Lakeshore Biomaterials

Lakeshore Biomaterials was a specialized biotechnology company focused on the development and manufacture of bioresorbable polymers for the pharmaceutical and medical device industries. The company was a global leader in poly(lactide-co-glycolide) (PLGA) chemistry, providing essential materials for controlled-release drug delivery systems. Their service offerings included custom polymer synthesis, formulation development, and GMP manufacturing of injectable depot products. Lakeshore Biomaterials played a critical role in enabling the long-term delivery of various therapeutic modalities, including small molecules, peptides, and proteins. In November 2008, the company was acquired by Evonik Industries, a move that significantly expanded Evonik's presence in the healthcare and drug delivery markets. Today, the legacy of Lakeshore Biomaterials continues as a key part of Evonik's Health Care business line in Birmingham, Alabama.